Navigation Links
Neuronascent to Present at Life Sciences Summit 2009
Date:9/15/2009

CLARKSVILLE, Md.., Sept. 15 /PRNewswire/ -- Neuronascent, Inc., a privately-held biotechnology company developing novel, neurogenic small-molecule drugs for the treatment of depression, Alzheimer's, Parkinson's and other neurodegenerative diseases, today announced that Dr. Judith Kelleher-Andersson, President and Chief Scientific Officer, will present at the Life Sciences Summit 2009 -- Showcasing Innovation, Promoting Collaboration. The Summit brings the world's leading companies together with the world's most innovative scientists to explore the next generation of biomedical solutions, the proceeds from which will help seed a bio-innovation research fund to support the discovery, development, translation, and commercialization of these new technologies. The event will take place on September 23-24, 2009 at Hyatt Regency Long Island in Hauppauge, New York.

"We are proud to have been selected to showcase the potential of our first-in-class CNS drug candidates and our neurogenesis platform," said Dr. Kelleher-Andersson. "Our participation in the Summit, with the nation's leading research institutions and top bioscience companies, supports our strategy for collaboration and innovation combining the best of business and the best of science."

About Neuronascent, Inc.:

Founded in 2004 by Dr. Judith Kelleher-Andersson, Neuronascent, discovers and develops first-in-class, small-molecule therapeutics, based on the science of neurogenesis, that target depression and neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The Company is headquartered in Clarksville, MD and has facilities in Rockville and Walkersville, MD. For additional information, please visit www.neuronascent.com.

About The Center for Biotechnology, A New York State Center for Advanced Technology in Medical Biotechnology:

The Center for Biotechnology is a cooperative research and development partnership between universities, private industry and New York State. Located on the campus of Stony Brook University, the Center's technology development initiative has contributed to an active pipeline of more than forty commercially promising technologies, the commercialization of more than a dozen novel biomedical products, and the formation of eighteen new bioscience companies. The Center is funded by the New York Office of Science, Technology and Academic Research (NYSTAR). Visit www.biotech.sunysb.edu for more information on the Center.


'/>"/>
SOURCE Neuronascent, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Martek to Present at Two Upcoming Investor Conferences
2. ViroPharma to Present at Four Additional Healthcare Conferences
3. Regado Biosciences to Present at the BioPharm America 2009 Conference on September 17, 2009
4. ERT to Present at UBS Global Life Sciences Conference on September 21, 2009
5. Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference
6. NovaBay(R) Presents Data Confirming Its Aganocide(R) Compounds Are Effective In Killing Bacteria That Have Developed Multidrug-Resistance
7. aTyr Pharma to Present at BioPharm America 2009
8. CryoLife to Present at UBS Global Life Sciences Conference
9. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting
10. Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference
11. Enox Biopharma Will Present Its Unique Self-Sterilizing Urinary Catheter at the 49th Annual ICAAC Meeting.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... will join the faculty of the University of North Carolina Kenan-Flagler Business ... strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international ...
(Date:6/27/2016)... June 27, 2016   Ginkgo Bioworks , a ... engineering, was today awarded as one of the ... the world,s most innovative companies. Ginkgo Bioworks is ... the real world in the nutrition, health and ... directly with customers including Fortune 500 companies to ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in ... peritoneal or pleural mesothelioma. Their findings are the subject of a new article on ... biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients that ...
Breaking Biology Technology:
(Date:6/2/2016)... June 2, 2016   The Weather Company , an ... Ads, an industry-first capability in which consumers will be able ... to ask questions via voice or text and receive relevant ... Marketers have long sought an advertising solution ... can be personal, relevant and valuable; and can scale across ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
Breaking Biology News(10 mins):